QL
RYTM icon

Quarry LP’s Rhythm Pharmaceuticals RYTM Stock Holding History

Quarry LP’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22K Buy
+29
New +$2.62K ﹤0.01% 1332
2026
Q1 		– Sell
-77
Closed -$8.24K – 2139
2025
Q4 		$8.24K Buy
+77
New +$8.17K ﹤0.01% 1483
2024
Q1 		– Sell
-1,500
Closed -$69K – 1872
2023
Q4 		$69K Buy
+1,500
New +$47.3K 0.01% 248

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Quarry LP's RYTM Position: Q2 2026 in Review

Quarry LP opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 29 shares worth $3.22K. The stake represents ﹤0.01% of the portfolio and ranks #1332 among its holdings. This is a return to the name: Quarry LP previously reported a position in RYTM as recently as Q4 2025.

Quarry LP first reported a position in RYTM in Q4 2023 and has held it in 3 quarters since. The position peaked at $69K in Q4 2023. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Quarry LP held 29 shares of Rhythm Pharmaceuticals worth $3.22K as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1332 holding.
  • Quarry LP first reported a position in Rhythm Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
  • Quarry LP's Rhythm Pharmaceuticals position peaked at $69K in Q4 2023.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.